Connect with a knowledgeable community and get your questions answered on IDNLearn.com. Join our interactive community and get comprehensive, reliable answers to all your questions.
Sagot :
Final answer:
The drug combination relieves hot flashes and prevents osteoporosis but does not reduce the risk of ovarian cancer.
Explanation:
Reduces the risk of ovarian cancer: The combination of transdermal conjugated estrogen and medroxyprogesterone does not reduce the risk of ovarian cancer.
Relieves hot flashes: This drug combination helps in relieving hot flashes, a common symptom of menopause.
Prevents osteoporosis: It aids in preventing osteoporosis by reducing the loss of calcium from bones.
Learn more about Menopausal hormone therapy here:
https://brainly.com/question/32155538
We value your participation in this forum. Keep exploring, asking questions, and sharing your insights with the community. Together, we can find the best solutions. Your search for solutions ends here at IDNLearn.com. Thank you for visiting, and come back soon for more helpful information.